A detailed history of Hsbc Holdings PLC transactions in Glaukos Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 7,031 shares of GKOS stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,031
Previous 6,637 5.94%
Holding current value
$1.06 Million
Previous $785,000 16.56%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.62 - $135.39 $44,766 - $53,343
394 Added 5.94%
7,031 $915,000
Q2 2024

Aug 12, 2024

SELL
$89.48 - $118.35 $6,263 - $8,284
-70 Reduced 1.04%
6,637 $785,000
Q1 2024

May 15, 2024

BUY
$76.4 - $96.33 $512,414 - $646,085
6,707 New
6,707 $632,000
Q4 2022

Feb 14, 2023

BUY
$40.82 - $57.75 $89,722 - $126,934
2,198 Added 24.26%
11,257 $491,000
Q3 2022

Nov 14, 2022

SELL
$46.84 - $58.49 $161,925 - $202,199
-3,457 Reduced 27.62%
9,059 $499,000
Q2 2022

Aug 11, 2022

SELL
$34.86 - $63.77 $43,819 - $80,158
-1,257 Reduced 9.13%
12,516 $564,000
Q1 2022

May 16, 2022

BUY
$44.33 - $57.82 $238,628 - $311,245
5,383 Added 64.16%
13,773 $821,000
Q4 2021

Feb 11, 2022

SELL
$40.27 - $56.99 $33,585 - $47,529
-834 Reduced 9.04%
8,390 $372,000
Q3 2021

Nov 12, 2021

BUY
$47.43 - $84.23 $437,494 - $776,937
9,224 New
9,224 $448,000
Q2 2021

Aug 13, 2021

SELL
$73.06 - $97.7 $311,893 - $417,081
-4,269 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$70.43 - $97.42 $164,876 - $228,060
-2,341 Reduced 35.42%
4,269 $358,000
Q4 2020

Feb 25, 2021

BUY
$48.9 - $75.26 $323,229 - $497,468
6,610 New
6,610 $497,000
Q2 2019

Aug 13, 2019

SELL
$63.59 - $78.71 $931,911 - $1.15 Million
-14,655 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$50.75 - $80.54 $743,741 - $1.18 Million
14,655 New
14,655 $1.15 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.